Oncimmune Holdings PLC Director/PDMR Shareholding (8353U)

TIDMONC

RNS Number : 8353U

Oncimmune Holdings PLC

27 October 2017

27 October 2017

Oncimmune Holdings plc

("Oncimmune" or the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR AND PERSONS CLOSELY ASSOCIATED WITH THEM

Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT(R) platform technology, today announces that on 25 October 2017, share options over 420,000 GBP0.01 ordinary shares of the Company were awarded to staff and directors (who are PDMRs) under the Company's 2016 Share Option Plan (an amalgamation of the Company's 2005 and 2007 Share Option Plans) as follows.

 
 Name               Position           Number of        Exercise price   Percentage of 
                                        Share Options    per Share        issued ordinary 
                                        Awarded                           share capital 
-----------------  -----------------  ---------------  ---------------  ----------------- 
 Meinhard           Non-executive 
  Schmidt            Chairman          300,000          GBP1.215         0.552% 
-----------------  -----------------  ---------------  ---------------  ----------------- 
                    Chief Financial 
 Andrew Millet       Officer           30,000           GBP1.215         0.055% 
-----------------  -----------------  ---------------  ---------------  ----------------- 
 Other employees 
  (not directors 
  or PDMR's)                           90,000           GBP1.215         0.165% 
------------------------------------  ---------------  ---------------  ----------------- 
 

The options are subject to the rules of the 2016 Share Option Plan and vest in five equal annual parts, the first fifth vesting on 27 October 2018 and each year thereafter for a further four years, subject to continued employment. Unless otherwise indicated in the table above, the options are exercisable at 121.5 pence, being the mid-market price of the Company's ordinary shares at the close of day on 25 October 2017

For further information:

Oncimmune Holdings plc

Geoffrey Hamilton-Fairley, Chief Executive Officer

[e-mail]

Zeus Capital Limited (Nominated Adviser and Broker)

Giles Balleny

[phone]

Media enquiries:

Consilium Strategic Communications

Chris Gardner, Mary-Jane Elliott, Matthew Neal, Lindsey Neville

[e-mail]

[phone]

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Meinhard Schmidt 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
                                                                Non-Executive Chairman, Director 
  a)    Position/status 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification/Amendment                           Initial Notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Oncimmune Holdings plc 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                                      213800HCYIWT6YPI1I02 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of         options over 1p ordinary shares - 2016 Share Option 
       instrument                                               Plan 
 
       Identification code 
                                                                ISIN GB00BYQ94H38 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Nature of the transaction                                Grant of options over ordinary shares 
----  -------------------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                 ----------  ---------- 
                                                                  N/A         300,000 
                                                                 ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 d)    Aggregated information                                    Price(s)    Volume(s) 
                                                                 ----------  ---------- 
                                                                  N/A         300,000 
                                                                 ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 e)    Date of the transaction                                  25 October 2016 
----  -------------------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 N/A 
----  -------------------------------------------------------  ------------------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Andrew Millet 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
                                                                Chief Financial Officer, Director 
  a)    Position/status 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Initial notification/Amendment                           Initial Notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                     Oncimmune Holdings Plc 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    LEI                                                      213800HCYIWT6YPI1I02 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of          options over 1p ordinary shares - 2016 Share Option 
       instrument                                                Plan 
 
       Identification code                                       ISIN GB00BYQ94H38 
----  -------------------------------------------------------  ------------------------------------------------------- 
 b)    Nature of the transaction                                Grant of options over ordinary shares 
----  -------------------------------------------------------  ------------------------------------------------------- 
 c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                 ----------  ---------- 
                                                                     N/A       30,000 
                                                                 ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
 d)    Aggregated information                                    Price(s)    Volume(s) 
                                                                 ----------  ---------- 
                                                                  N/A         30,000 
                                                                 ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 

 e)    Date of the transaction                                  25 October 2017 
----  -------------------------------------------------------  ------------------------------------------------------- 
 f)    Place of the transaction                                 N/A 
----  -------------------------------------------------------  ------------------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGCBDGGXDBGRR

(END) Dow Jones Newswires

October 27, 2017 05:32 ET (09:32 GMT)